|
Market Closed -
Nasdaq
00:00:00 24/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 14.39 USD | +2.49% |
|
+7.47% | +286.83% |
| 10-16 | Erasca Chief Operating Officer to Depart; Shares Fall | MT |
| 10-16 | Erasca, Inc. Announces Termination of Nicholas Chetwyn as Chief Operating Officer, Effective November 2, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ERASCA, INC. | Other Biotechnology & Medical Research | +2.49% | +7.47% | +286.83% | +551.13% | -23.82% | 5.03B |  |  |  |
- Stock Market
- Stocks
- ERAS Stock
- Charts Erasca, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
